Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Bronchiolitis Obliterans Syndrome × bosutinib × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Myeloproliferative Disorders 1 Leukemia 1 Bronchiolitis Obliterans Syndrome 1 Blast Crisis 1

Interventions

ziconotide 1 ruxolitinib 1 bosutinib 1 asciminib 1 Panobinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02228382 2021-12-30

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Pfizer

Phase 4 Terminated

163 enrolled 27 charts

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡